The inference that disease X is two times more prevalent in city B than city A using mortality rates is flawed because of failing to distinguish between prevalence and what?

The inference that disease X is two times more prevalent in city B than city A using mortality rates is flawed because of failing to distinguish between prevalence and what?

• A. Incorrect, because of failure to distinguish between prevalence and mortality
• B. Correct
• C. Incorrect, because of failure to adjust for differences in age distributions
• D. Incorrect, because of failure to distinguish between period and point prevalence

Answer: (A)

Understanding the difference between prevalence and mortality is the key idea here. Prevalence is the proportion of people who have a disease at a specific time (or during a period), reflecting both new cases (incidence) and how long people live with the disease (duration). Mortality rate, on the other hand, is the rate at which people die from the disease over a time interval. These are fundamentally different measures. Using mortality rates to infer how common the disease is in a population assumes a direct link between the number of deaths and the number of people living with the disease, which isn’t valid unless you know how long people live with the disease, how often it occurs (incidence), and how deadly it is (case fatality). Differences in survival, treatment, age structure, or other factors can change mortality without reflecting the same changes in prevalence. So the inference that disease X is twice as prevalent in city B based on mortality rates is flawed because it conflates two distinct epidemiologic measures. While age distribution or period versus point prevalence are relevant methodological considerations in prevalence studies, the core mistake here is treating mortality as if it directly reflected prevalence.

Understanding the difference between prevalence and mortality is the key idea here. Prevalence is the proportion of people who have a disease at a specific time (or during a period), reflecting both new cases (incidence) and how long people live with the disease (duration). Mortality rate, on the other hand, is the rate at which people die from the disease over a time interval. These are fundamentally different measures.

Using mortality rates to infer how common the disease is in a population assumes a direct link between the number of deaths and the number of people living with the disease, which isn’t valid unless you know how long people live with the disease, how often it occurs (incidence), and how deadly it is (case fatality). Differences in survival, treatment, age structure, or other factors can change mortality without reflecting the same changes in prevalence. So the inference that disease X is twice as prevalent in city B based on mortality rates is flawed because it conflates two distinct epidemiologic measures.

While age distribution or period versus point prevalence are relevant methodological considerations in prevalence studies, the core mistake here is treating mortality as if it directly reflected prevalence.